Uptake of nickel(II) by human peripheral mononuclear leukocytes.
Dithiocarbamate-mediated nickel(II) uptake by human peripheral mononuclear leukocytes (mostly lymphocytes) was examined. The lipophilic ligands diethyldithiocarbamate (DDC) and ammonium pyrrolidinedithiocarbamate (APDC) enhanced the cellular association of nickel(II), while ammonium dithiocarbamate (AD) had no effect. Sequential incubations (ligand first followed by nickel(II)) and concurrent experiments (simultaneous exposure) yielded similar results. Cell fractionation studies showed that DDC promoted cytosolic accumulation of nickel(II), rather than in the residual cell pellet. The observations reported are interpreted in terms of the "Equilibrium" model of metal-ion uptake by cells proposed by Professor Williams. Although nickel(II) transformed lymphocytes in vitro from an individual with dermal manifestation of nickel sensitivity to lymphoblasts, there was no apparent difference in nickel(II) uptake capacity over lymphocytes from nonsensitized controls.
D001692:Biological Transport; D006801:Humans; D007700:Kinetics; D007962:Leukocytes / Q000378:metabolism*; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D009000:Monocytes / Q000378:metabolism; D009532:Nickel / Q000097:blood*; D013859:Thiocarbamates / Q000494:pharmacology*
D013859:Thiocarbamates; D009532:Nickel